Fiztasovimab - CAS 2467411-25-0

Fiztasovimab (NPC-21; EV2038), a fully human IgG1λ monoclonal antibody (mAb), targets human cytomegalovirus (hCMV) . It exerts its neutralizing activity through binding to the antigenic domain 1 of glycoprotein B on the hCMV envelope, effectively inhibiting cell-to-cell transmission of hCMV [1].

Virus Protease

Microbiology/Virology

2467386

-20°C

Ice Packs

Inhibitory Antibodies